Director, Regulatory Affairs
MMS Holdings
Ben Kaspar has over 15 years of regulatory strategy, regulatory submission, and medical writing experience with an emphasis on coordination and planning of multinational clinical trials. Specializing in early development, rare diseases, and Alzheimer’s disease, Ben has supported clinical trial startup activities for multiple sponsors across all phases of clinical development.
Disclosure information not submitted.
Lessons on the EU-Clinical Trials Regulation
Thursday, October 5, 2023
8:00 AM – 9:15 AM EDT